explore -WSS

explore

author：fashion 2025-09-27 22:05:35 - browse：63442

Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug Administration this week lurk numerous questions. And one of them may be whether the company was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.

At issue is a trial that Amgen is relying upon to win final approval for Lumakras, which the FDA approved on a conditional basis in 2021. This process, known as accelerated approval, required the company to run a confirmatory study. But ahead of an advisory panel meeting on Thursday, the agency released documents showing its staff found “potential systemic bias” in the trial.

The disclosure throws into question the future of this drug, which has offered hope to patients for whom an effective treatment previously seemed out of reach. Some Wall Street analysts are now betting the FDA will ask Amgen to run yet another trial or maybe withdraw the drug altogether. Either way, the prognosticators are reworking their calculus for Amgen stock.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： First medicine developed to treat MASH expected to be approved soon

focus

WSS

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

How to protect coverage of PrEP

Amylyx ALS drug fails large clinical trial

Precocious puberty in girls comes with mental health risks

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Wikipedia

explore

focus

Supreme Court strikes down use of affirmative action

With psoriasis trial ahead, Alumis raises $259 million

Wildfire smoke exposes gaps in outdoor worker protections

With psoriasis trial ahead, Alumis raises $259 million

FDA approval of Sarepta Duchenne genetic therapy gives me hope

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Continuity nursing helped my family in our darkest PICU moments

FAMU bans football players from facility after release of rap video shot in team's locker room

Medicare details structure of new drug price negotiation program

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

hotspot

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Thousands protest mob assault of women who were paraded naked in remote Indian border state

4 missing after record

Where does female orgasm come from? Scientists think they know

Change Healthcare payments predicted restored March 15

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

hotspot

focus

focus

Wikipedia